Perjeta (pertuzumab) supply for hospitals & distributors
HER2 dimerisation inhibitor (monoclonal antibody) · Roche
Perjeta (pertuzumab) is Roche's anti-HER2 monoclonal antibody that blocks HER2 dimerisation. It is used together with trastuzumab and chemotherapy in HER2-positive breast cancer and is supplied as a refrigerated IV concentrate.
Prescription-only medicine. No prices are published. Supply is to hospitals, distributors, pharmacies and physicians against a valid prescription or purchase order. This page is product information, not medical advice.
Product facts
Strengths and presentation
- 420 mg/14 mL (30 mg/mL) concentrate for solution for infusion, single-use vial
Approved indications (EMA / FDA label summary)
- HER2-positive early breast cancer — neoadjuvant treatment, with trastuzumab and chemotherapy
- HER2-positive early breast cancer at high risk of recurrence — adjuvant treatment
- HER2-positive metastatic or locally recurrent unresectable breast cancer, with trastuzumab and docetaxel
Short label summary only. Approved indications differ by country and line of therapy; the national label in the destination country governs.
Storage and cold chain
- Store refrigerated at 2–8 °C in the original carton to protect from light
- Do not freeze; do not shake
- Shipped in validated cold-chain packaging with temperature data logging
How we supply
- Original manufacturer packs only — sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
- Batch number and expiry confirmed in writing before dispatch; every pack is traceable to its batch.
- Documents with every consignment: commercial invoice, batch / CoA information from the source, and packing list.
- Validated 2–8 °C cold-chain shipping with a temperature data logger from origin to handover.
- Named-patient and special-import support: we prepare the paperwork your hospital or importer needs for the local regulator.
Procurement notes
Perjeta starts with an 840 mg loading dose (two vials) followed by 420 mg (one vial) every 3 weeks. Most orders therefore pair Perjeta with Herceptin; we can quote both in a single cold-chain shipment.
Who we supply
- Hospital pharmacy and procurement departments
- Licensed pharmaceutical distributors and importers
- Oncology and haematology centres
- Treating physicians arranging named-patient supply
Markets served
United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq. Import into each country follows that country's regulator (for example MOHAP / DoH / DHA, SFDA, MoPH, Kuwait MOH, Oman MOH, NHRA) — we work with the receiving institution's import route.
Frequently asked questions
Can you supply Perjeta together with Herceptin?
Yes. Pertuzumab is used with trastuzumab, so both Roche products are commonly quoted and shipped together, each with its own batch documents.
How many Perjeta vials does a cycle need?
Per the label, the loading dose is 840 mg (two 420 mg vials) and maintenance is 420 mg (one vial) every 3 weeks. The treating team confirms the protocol.
Is the Perjeta you supply an original manufacturer pack?
Yes. We supply Perjeta only in the original Roche pack, sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
Which documents come with a consignment?
Commercial invoice, batch / CoA information from the source and a packing list, with batch number and expiry for every pack. Additional documents requested by your importer can be prepared.
Do you supply the UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq?
Yes — to hospitals, distributors and licensed centres in these countries, through the import or named-patient route accepted by the destination country's regulator.
How do I get a quote for Perjeta?
Send a supply inquiry on WhatsApp with strength, quantity, country and institution. We reply with a written quote, availability and expiry; we do not publish prices on the site.
Send a supply inquiry
Tell us the product, strength, quantity, destination country and the receiving institution. We reply with availability, batch/expiry and the documentation set — and a written quote. We do not sell to the public.
Send a supply inquiryOther medicines we supply to the Gulf
- Keytruda (pembrolizumab)
- Opdivo (nivolumab)
- Enhertu (trastuzumab deruxtecan)
- Tagrisso (osimertinib)
- Darzalex (daratumumab)
- Imfinzi (durvalumab)
- Tecentriq (atezolizumab)
- Kadcyla (trastuzumab emtansine)
- Lynparza (olaparib)
- Revlimid (lenalidomide)
- Imbruvica (ibrutinib)
- Venclyxto (venetoclax)
- Xtandi (enzalutamide)
- Adcetris (brentuximab vedotin)
Sources
Reviewed by Pharmacy Remedy Pharmacovigilance & Compliance Desk · Last updated: 2026-11-04